BMO's top oil & gas analyst eyes four-way 'Montney Mash' mega merger
Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney ...
ETF Daily News4d
BMO Capital Markets Issues Positive Forecast for Protagonist Therapeutics (NASDAQ:PTGX) Stock Price
BMO Capital Markets’ price target suggests a potential upside of 24.89% from the stock’s current price. A number of other brokerages have also issued reports on PTGX.
Tech is floundering – but ‘critical’ selectivity can still offer you outperformance – BMO
Belski, chief investment strategist at BMO Capital Markets. The performance of technology (NYSEARCA:XLK) against the S&P 500 ...
Yahoo Finance5d
BMO Capital Initiates Coverage on Dyne Therapeutics With Outperform Rating
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
Lack of follow-through in post-CPI Treasury rally shows traders focused on tariff fears: strategist
A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...
BMO Capital Markets Issues Pessimistic Forecast for GE Vernova (NYSE:GEV) Stock Price
GE Vernova (NYSE:GEV – Free Report) had its price objective lowered by BMO Capital Markets from $471.00 to $420.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has ...
Okta price target raised to $130 from $105 at BMO Capital
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...
SailPoint initiated with an Outperform at BMO Capital
BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...